Search research articles
Contact Us
Filters
Showing results (391-400 of 475) with videos related to
Page
of 48
Sort By:
Epilepsia
|
December 15, 2023
Letter regarding "Seizure control in women with epilepsy undergoing assisted reproductive technology"
Barbara M Decker, Heidi Munger Clary, Manisha G Holmes, et al.
ACS Chemical Neuroscience
|
February 3, 2015
Effect of 1-substitution on tetrahydroisoquinolines as selective antagonists for the orexin-1 receptor
David A Perrey, Nadezhda A German, Ann M Decker, et al.
Obesity Science & Practice
|
October 14, 2022
Psychosocial predictors of problematic eating in young adults who underwent adolescent bariatric surgery
Kristina M Decker, Jennifer Reiter-Purtill, Carolina M Bejarano, et al.
Oncotarget
|
March 31, 2016
Endogenous GAS6 and Mer receptor signaling regulate prostate cancer stem cells in bone marrow
Younghun Jung, Ann M Decker, Jingcheng Wang, et al.
Journal of Cellular Biochemistry
|
October 19, 2016
Mer Tyrosine Kinase Regulates Disseminated Prostate Cancer Cellular Dormancy
Frank C Cackowski, Matthew R Eber, James Rhee, et al.
Journal of Molecular Biology
|
July 16, 2008
Combinatorial optimization of a CD4-mimetic miniprotein and cocrystal structures with HIV-1 gp120 envelope glycoprotein
François Stricher, Chih-chin Huang, Anne Descours, et al.
Journal of Medicinal Chemistry
|
July 24, 2018
Potent and Selective Tetrahydroisoquinoline Kappa Opioid Receptor Antagonists of Lead Compound (3 R)- N-[1 R)-1-(Cyclohexylmethyl)-2-methylpropyl]-7-hydroxy-1,2,3,4-tetrahydroisoquinoline-3-carboxamide (CDTic)
Chad M Kormos, Pauline W Ondachi, Scott P Runyon, et al.
Journal of Medicinal Chemistry
|
August 18, 2018
Potent and Selective Tetrahydroisoquinoline Kappa Opioid Receptor Antagonists of Lead Compound (3 R)-7-Hydroxy- N-[(1 S)-2-methyl-1-(piperidin-1-ylmethyl)propyl]-1,2,3,4-tetrahydroisoquinoline-3-carboxamide (PDTic)
Pauline W Ondachi, Chad M Kormos, Scott P Runyon, et al.
Journal of Virology
|
April 6, 2007
Dissecting the neutralizing antibody specificities of broadly neutralizing sera from human immunodeficiency virus type 1-infected donors
Amandeep K Dhillon, Helen Donners, Ralph Pantophlet, et al.
Journal of Virology
|
March 8, 2013
Heterogeneity in neutralization sensitivities of viruses comprising the simian immunodeficiency virus SIVsmE660 isolate and vaccine challenge stock
Michael Lopker, Juliet Easlick, Sarah Sterrett, et al.
Page
of 48
Search research articles
Search
Showing results (391-400 of 475) with videos related to
Sort By:
Page
of 48
Epilepsia
|
December 15, 2023
Letter regarding "Seizure control in women with epilepsy undergoing assisted reproductive technology"
Barbara M Decker, Heidi Munger Clary, Manisha G Holmes, et al.
ACS Chemical Neuroscience
|
February 3, 2015
Effect of 1-substitution on tetrahydroisoquinolines as selective antagonists for the orexin-1 receptor
David A Perrey, Nadezhda A German, Ann M Decker, et al.
Obesity Science & Practice
|
October 14, 2022
Psychosocial predictors of problematic eating in young adults who underwent adolescent bariatric surgery
Kristina M Decker, Jennifer Reiter-Purtill, Carolina M Bejarano, et al.
Oncotarget
|
March 31, 2016
Endogenous GAS6 and Mer receptor signaling regulate prostate cancer stem cells in bone marrow
Younghun Jung, Ann M Decker, Jingcheng Wang, et al.
Journal of Cellular Biochemistry
|
October 19, 2016
Mer Tyrosine Kinase Regulates Disseminated Prostate Cancer Cellular Dormancy
Frank C Cackowski, Matthew R Eber, James Rhee, et al.
Journal of Molecular Biology
|
July 16, 2008
Combinatorial optimization of a CD4-mimetic miniprotein and cocrystal structures with HIV-1 gp120 envelope glycoprotein
François Stricher, Chih-chin Huang, Anne Descours, et al.
Journal of Medicinal Chemistry
|
July 24, 2018
Potent and Selective Tetrahydroisoquinoline Kappa Opioid Receptor Antagonists of Lead Compound (3 R)- N-[1 R)-1-(Cyclohexylmethyl)-2-methylpropyl]-7-hydroxy-1,2,3,4-tetrahydroisoquinoline-3-carboxamide (CDTic)
Chad M Kormos, Pauline W Ondachi, Scott P Runyon, et al.
Journal of Medicinal Chemistry
|
August 18, 2018
Potent and Selective Tetrahydroisoquinoline Kappa Opioid Receptor Antagonists of Lead Compound (3 R)-7-Hydroxy- N-[(1 S)-2-methyl-1-(piperidin-1-ylmethyl)propyl]-1,2,3,4-tetrahydroisoquinoline-3-carboxamide (PDTic)
Pauline W Ondachi, Chad M Kormos, Scott P Runyon, et al.
Journal of Virology
|
April 6, 2007
Dissecting the neutralizing antibody specificities of broadly neutralizing sera from human immunodeficiency virus type 1-infected donors
Amandeep K Dhillon, Helen Donners, Ralph Pantophlet, et al.
Journal of Virology
|
March 8, 2013
Heterogeneity in neutralization sensitivities of viruses comprising the simian immunodeficiency virus SIVsmE660 isolate and vaccine challenge stock
Michael Lopker, Juliet Easlick, Sarah Sterrett, et al.
Page
of 48